Doehring Caroline, Sundrum Albert
Department of Animal Nutrition and Animal Health, University of Kassel, Nordbahnhofstraße 1a, D-37213, Witzenhausen, Germany.
Department of Animal Nutrition and Animal Health, University of Kassel, Nordbahnhofstraße 1a, D-37213, Witzenhausen, Germany.
Prev Vet Med. 2019 Apr 1;165:63-70. doi: 10.1016/j.prevetmed.2019.02.004. Epub 2019 Feb 11.
This paper addresses whether it is worthwhile investing time in a more comprehensive documentation and analysis of farm specific data for mastitis treatment. Whilst most farmers keep some records, many refrain from investing more effort in making them more detailed. Therefore, information on farm-specific antibiotic consumption, effectiveness of treatments and the costs of mastitis are lacking; as well as the ability to identify and realise possibilities for improvement. An observational study was conducted on 30 dairy farms, to obtain an overview of farming practice, recording detailed data (using herd management software) on: milk records, diagnostics, preventive and therapeutic treatments and cost of mastitis, on an individual cow level. Out of a total of 30,633 cows, 67% received medication for the treatment or prevention of mastitis over a year. Antibiotics were chosen for 96% of udder treatments; including those for dry cows. Over 32% of the antibiotics used during lactation belonged to the 'highest priority critically important antimicrobial' category. Success of therapeutic treatment (assessed by individual somatic cell count (SCC)) ranged from 18% to 59% and total costs of mastitis per cow and year from € 158 to € 483. The high variations in antibiotic consumption, treatment outcomes and cost of mastitis between farms, showed that average or incomplete figures risk giving the wrong impression of a farm. It is thus worthwhile to invest in documentation and analysis of data, so that it is clear where action is required and which investments can be expected to be financially feasible. Benefits emerge from knowledge of antibiotic consumption allowing monitoring and reduction in antibiotic use (as demanded by consumers and legislation), improvements in animal health and welfare thanks to regular checks of how effective a treatment is, and economic benefits due to knowledge of the costs caused by mastitis.
本文探讨了投入时间对乳腺炎治疗的农场特定数据进行更全面的记录和分析是否值得。虽然大多数农民会保留一些记录，但许多人不愿投入更多精力使其更详细。因此，缺乏关于农场特定抗生素使用情况、治疗效果和乳腺炎成本的信息；也缺乏识别和实现改进可能性的能力。对30个奶牛场进行了一项观察性研究，以了解养殖实践概况，在个体奶牛层面上使用畜群管理软件记录详细数据，包括：牛奶记录、诊断、预防和治疗措施以及乳腺炎成本。在总共30633头奶牛中，67%在一年中接受了治疗或预防乳腺炎的药物。96%的乳房治疗选择了抗生素，包括干奶牛的治疗。泌乳期间使用的抗生素中，超过32%属于“最高优先级极为重要的抗菌药物”类别。治疗成功率（通过个体体细胞计数（SCC）评估）在18%至59%之间，每头奶牛每年的乳腺炎总成本在158欧元至483欧元之间。不同农场之间抗生素使用、治疗结果和乳腺炎成本的差异很大，这表明平均或不完整的数据可能会给农场造成错误印象。因此，投入时间进行数据记录和分析是值得的，这样可以明确需要采取行动的地方以及哪些投资在经济上是可行的。了解抗生素使用情况有助于监测和减少抗生素使用（这是消费者和法规所要求的），定期检查治疗效果有助于改善动物健康和福利，了解乳腺炎造成的成本还能带来经济效益，这些都是这样做的好处。
